Program Learning Objectives

The goal of the USC Biopharmaceutical Marketing program is to prepare graduates with practical tools, skills, and methods to advance the next wave of healthcare innovation.

Degree Requirements

The MS in Biopharmaceutical Marketing degree requires the completion of 30 units with a cumulative GPA of at least 3.0.

Accordion Content
  • BPMK 500 Biopharmaceutical Marketing Management (3 units)
  • BPMK 504 Market Access & Reimbursement Strategy (3 units)
  • BPMK 508 Biopharmaceutical Marketing Research and Analytics (3 units)
  • HCDA 500 U.S. Health Systems: Healthcare Access and Delivery (3 units)
  • HCDA 503 Competitive Healthcare Intelligence (3 units)
  • HCDA 507 Foundations of Product Development and Commercialization (3 units)

Elective courses are generally a combination of BPMK courses and HCDA courses.

Courses are selected in consultation with your academic advisor. For more information about course offerings, visit the USC Course Catalogue or contact Michelle Ton, program administrator, at tonm@usc.edu.

Enterprise Team Projects

In the complex, dynamic world of healthcare, commercial teams are challenged to perform multiple feats: launch new products, gain formulary status, increase margins, expand market share, and outwit competitors — usually against impossibly tight deadlines.

Now, a commercial organization with more projects than people to manage them can speed results and shorten their list by outsourcing a project to a team of graduate students from the USC Healthcare Decision Analysis & Biopharmaceutical Marketing programs.

The USC Enterprise Team Projects team consists of 5-7 graduate students who contribute approximately 1,200 hours to the effort over four months.

Projects can be structured around problems or opportunities including new product commercializationvalue and accesspricing and reimbursementcompetitive intelligenceproduct marketingbrand strategypipeline and business development, and other key business areas.

Working Professionals Cohort

Flexible, innovative Master of Science (MS) program will prepare students for excellence in Healthcare Decision Analysis or Biopharmaceutical Marketing.

In an effort to accommodate working professionals who want to accelerate their skills and expertise while still meeting their professional work demands, USC Mann now offers a Working Professionals Cohort (WPC) within the Biopharmaceutical Marketing and Healthcare Decision Analysis master’s degree programs.

Designed for flexibility, courses are offered on two weekends and select weeknights. Students have the option to participate from campus, home, the office or even while traveling to meet professional work demands.

USC Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.